Contact this trialFirst, we need to learn more about you.
Antidepressant
TS-161 for Treatment-Resistant Depression
Recruiting0 awardsPhase 2
Bethesda, Maryland
This trial is testing a new drug, TS-161, to see if it improves symptoms of depression in people with MDD. Eligible participants must be 18-65 years old with MDD without psychotic features. The trial will last 12-16 weeks, and participants will complete interviews, physical exams, psychological tests, surveys, and MRI and MEG scans.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.